Tim Missey

Tim Missey has extensive experience in the pharmaceutical industry, with a focus on sales, marketing, and commercial operations. Tim is currently the VP of Sales & Commercial Operations at Avadel Pharmaceuticals plc since October 2022. Prior to that, they held the position of Chief Commercial Officer at EVERSANA from July 2021 to October 2022.

Before joining EVERSANA, Tim served as President at ATJ Consulting from 2019 to 2021, where they developed sustainable commercial strategies for pharmaceutical and biotech clients, with a focus on rare disease patient populations. Tim was responsible for various projects, including primary market research, competitive analysis, go-to-market strategy, and sales force deployments.

From 2018 to 2019, Tim was the President - North America at STEM Healthcare, a UK-based consultancy. In this role, they drove brand strategy for over 40 companies, including biotech start-ups and major pharmaceutical companies. Tim worked on developing the strategic transformation of the company from proof of concept to a rapidly growing, sustainable business.

Prior to that, Tim held various leadership positions at Mallinckrodt Pharmaceuticals. From 2015 to 2017, they served as VP/GM Sales & Marketing, Neurological Rare Diseases, where they had P&L responsibility for H.P. Acthar Gel® indications in Infantile Spasms and Multiple Sclerosis relapses. Tim also held the role of Global Lead and VP/GM Sales & Marketing, Intrathecal Therapies, where they were responsible for a drug/device combination therapy for severe spasticity treatment across multiple neurological disease states.

Tim's earlier roles at Mallinckrodt Pharmaceuticals include Chief of Staff to the President and CEO, Global Marketing Director - API's, Sales Director, US Field Sales Executive, Product Manager, Quality Lab Manager, and Quality Analyst.

Overall, Tim Missey has a strong background in sales, marketing, and commercial operations within the pharmaceutical industry, with a focus on rare diseases and neurological disorders.

Tim Missey received their MBA from Washington University in St. Louis - Olin Business School between 2005 and 2007. Prior to that, they obtained a Bachelor's degree in Chemistry from Loyola University Chicago, completing their studies in 1998.